Publications by authors named "Z Esin Celik"
Purpose: This study aims to compare the surface roughness (SR), contact angle (CA), surface free energy (SFE), and bacterial adhesion of resin-based materials used in additive, subtractive, and conventional manufacturing techniques.
Materials And Methods: This study involved four groups of 23 specimens: Indirect conventional resin composite (ICRC), subtractively manufactured resin composite (SMRC), additively manufactured resin composite (AMRC), and soda-lime-silica glass (SLSG). One specimen per group was analyzed by Energy Dispersive X-ray Spectroscopy (EDS) before polishing.
Objectives: Some species of L. are popularly used to treat gastric ulcers. However, the possible healing mechanisms of the anti-ulcer activity of , which has proven antioxidant, anti-inflammatory, and wound-healing properties, are unclear.
View Article and Find Full Text PDFArticle Synopsis
- * Results showed probable PTSD at 21.4%, depression at 15.9%, and complicated grief at a high 64.7%.
- * Key risk factors for PTSD included loss of a loved one and fear of future earthquakes, while depression was linked to being trapped during the quakes and fear experienced during the event; both conditions were correlated with reduced perceived life control.
Article Synopsis
- The study aimed to investigate genetic changes in tumors from patients with synchronous endometrial ovarian cancer, using next-generation sequencing over a period of 5 years.
- DNA was extracted from preserved tissue samples, and sequencing was performed with advanced techniques to identify mutations in several key genes linked to cancer.
- Results showed a high prevalence of likely pathogenic or pathogenic mutations in genes like ATM and BRCA2 in both endometrial and ovarian tissues, confirming significant genetic alterations in most cases of synchronous cancer.
Article Synopsis
- Ado-trastuzumab emtansine (T-DM1) is a targeted therapy for HER2-positive breast cancer, commonly causing side effects like fatigue, diarrhea, and thrombocytopenia.
- A 54-year-old woman treated for metastatic breast cancer developed drug-induced lupus after 18 months on T-DM1, which improved upon stopping the drug and starting hydroxychloroquine.
- This case is notable as it documents the first reported instance of drug-induced lupus specifically linked to T-DM1 therapy.